November 15, 2016 - By Marguerite Chambers · 0 Comments
Bioamber Inc (NYSE:BIOA) institutional sentiment decreased to 0.82 in Q2 2016. Its down -0.43, from 1.25 in 2016Q1. The ratio turned negative, as 9 active investment managers started new or increased holdings, while 11 cut down and sold stakes in Bioamber Inc. The active investment managers in our partner’s database reported: 11.17 million shares, down from 12.19 million shares in 2016Q1. Also, the number of active investment managers holding Bioamber Inc in their top 10 holdings was flat from 0 to 0 for the same number . Sold All: 2 Reduced: 9 Increased: 8 New Position: 1.
BioAmber Inc. , formerly DNP Green Technology, Inc., is an industrial biotechnology company, which produces sustainable chemicals. The company has a market cap of $149.26 million. The Company’s technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstocks into sustainable chemicals that are replacements for petroleum-derived chemicals, which are used in a range of everyday products, including plastics, food additives and personal care products. It currently has negative earnings. The Company’s geographical divisions include Europe and North America.
About 49,963 shares traded hands. Bioamber Inc (NYSE:BIOA) has risen 13.10% since April 13, 2016 and is uptrending. It has outperformed by 9.17% the S&P500.
According to Zacks Investment Research, “BioAmber Inc. is a bio-based chemicals company. It produces and sells bio-succinic acid. The company’s technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstock into chemicals for use in products including plastics, resins, food additives and personal care products. It operates in France, China, Canada, and the United States. BioAmber Inc. is based in Plymouth, Minnesota.”
Robecosam Ag holds 0.11% of its portfolio in Bioamber Inc for 400,000 shares. Essex Investment Management Co Llc owns 101,362 shares or 0.05% of their US portfolio. Moreover, Waddell & Reed Financial Inc has 0.05% invested in the company for 8.62 million shares. The Connecticut-based Ardsley Advisory Partners has invested 0.03% in the stock. Hilltop Holdings Inc., a Texas-based fund reported 18,000 shares.#img1#
Insider Transactions: Since January 1, 0001, the stock had 4 buys, and 0 insider sales for $214,506 net activity.
BioAmber Inc. (BioAmber), formerly DNP Green Technology, Inc., incorporated on October 15, 2008, is an industrial biotechnology company, which produces sustainable chemicals. The Company’s technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstocks into sustainable chemicals that are replacements for petroleum-derived chemicals, which are used in a range of everyday products, including plastics, resins, food additives and personal care products. The Company’s geographical divisions include Europe and North America. The Firm sells its product, bio-succinic acid, to clients in a range of chemical markets. Bio-succinic acid is a biologically produced, chemically identical replacement for petroleum-derived succinic acid that can be utilized to produce derivative products, such as bio 1,4 Butanediol (1,4 BDO), and can substitute petrochemicals, such as maleic anhydride, phthalic acid and adipic acid in various applications. The Company’s bio specialty chemicals can be used in multiple end-markets and applications, and serves as building blocks for a range of products used every day. Bio-succinic acid is used in various applications, including plasticizers, polyurethanes, resins and coatings, de-icing and coolant solutions, fine chemicals and lubricants, as well as anti-freeze solutions, coolants solvents, water treatment chemicals, laundry tablets and bath salts, artificial leather products, and foams made with recycled polyethylene terephthalate (PET).
More news for Bioamber Inc (NYSE:BIOA) were recently published by: Quotes.Wsj.com, which released: “BioAmber Inc. BIOA (US: NYSE)” on April 27, 2013. Reuters.com‘s article titled: “BRIEF-Bioamber Inc reports Q3 loss per share $0.21” and published on March 26, 2013 is yet another important article.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Marguerite Chambers